Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin

Research output: Contribution to journalJournal articlepeer-review

  • A. Mangia
  • O. Dalgard
  • N. Minerva
  • H. Verbaan
  • D. Bacca
  • Helmer Ring Larsen
  • M. Copetti
  • V. Caretta
  • V. Piazzollla
  • R. Cozzolongo
  • L. Mottola
  • A. Andriulli
Original languageEnglish
JournalAlimentary Pharmacology and Therapeutics
Volume31
Issue number12
Pages (from-to)1346-53
Number of pages7
ISSN0269-2813
Publication statusPublished - 1 Jun 2010

ID: 33788360